Global incidence of multidrug-resistant tuberculosis
- PMID: 16845631
- DOI: 10.1086/505877
Global incidence of multidrug-resistant tuberculosis
Abstract
Background: The global number of incident cases of multidrug-resistant (MDR) tuberculosis (TB) in 2000 was estimated to be 272,906 (95% confidence interval [CI], 184,948-414,295). For accurate planning of TB control programs, this estimate and others have been revised using data from additional countries and by including in the model previously treated TB cases, which had not been accounted for in the previous analysis.
Methods: Multiple logistic regression was used to identify variables that were predictive of MDR-TB frequency among new and previously treated cases surveyed in 90 and 77 countries, respectively. These variables were then used to estimate MDR-TB frequencies in countries that had not been surveyed.
Results: The total number of MDR-TB cases estimated to have occurred worldwide in 2004 is 424,203 (95% CI, 376,019-620,061), or 4.3% (95% CI, 3.8%-6.1%) of all new and previously treated TB cases. In the same year, 181,408 (95% CI, 135,276-319,017) MDR-TB cases were estimated to have occurred among previously treated TB cases alone. Three countries--China, India, and the Russian Federation--accounted for 261,362 (95% CI, 180,779-414,749) MDR-TB cases, or 62% of the estimated global burden.
Conclusions: These updated sets of estimates incorporating previously treated TB cases call for an urgent plan to expand appropriate diagnostic and treatment services for patients with MDR-TB in low-resource settings.
Similar articles
-
Worldwide incidence of multidrug-resistant tuberculosis.J Infect Dis. 2002 Apr 15;185(8):1197-202. doi: 10.1086/339818. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930334
-
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.Bull World Health Organ. 2002;80(6):489-95; discussion 495-500. Bull World Health Organ. 2002. PMID: 12132008 Free PMC article.
-
Risk factors for multidrug-resistant tuberculosis in Hong Kong.Int J Tuberc Lung Dis. 2008 Sep;12(9):1065-70. Int J Tuberc Lung Dis. 2008. PMID: 18713506
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005. Br Med Bull. 2005. PMID: 15956357 Review.
Cited by
-
Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States.PLoS One. 2012;7(2):e32158. doi: 10.1371/journal.pone.0032158. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384165 Free PMC article.
-
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.PLoS One. 2012;7(1):e30194. doi: 10.1371/journal.pone.0030194. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272302 Free PMC article.
-
Info-gap management of public health Policy for TB with HIV-prevalence and epidemiological uncertainty.BMC Public Health. 2012 Dec 19;12:1091. doi: 10.1186/1471-2458-12-1091. BMC Public Health. 2012. PMID: 23249291 Free PMC article.
-
Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis.Antimicrob Agents Chemother. 2012 Jul;56(7):3857-63. doi: 10.1128/AAC.00048-12. Epub 2012 May 7. Antimicrob Agents Chemother. 2012. PMID: 22564839 Free PMC article. Clinical Trial.
-
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.BMC Infect Dis. 2009 Aug 28;9:142. doi: 10.1186/1471-2334-9-142. BMC Infect Dis. 2009. PMID: 19715569 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous